Utah is building the operating rules for medical cannabis assistance, with eligibility, available funding and the nonprofit administrator still central...
Two draft approaches would raise Alaska’s concentrate allowance, but their THC calculations and the next rulemaking steps need to be read separately.
The November 17 agenda puts draft recommendations before North Carolina’s cannabis council, with competing retail models and a December report still ahead.
New York’s November 19–20 program pairs cannabis research with clinical care, public health and a separate practitioner training course.
The first EUDA Drug Survey separates perceptions of cannabis availability from opinions about regulation—and from evidence of actual use.
Boots has launched a private medical cannabis service for eligible adults. Specialist assessment and ongoing reviews remain central to access.
A Senate spending proposal retains state medical cannabis language and leaves out the House’s rescheduling funding restriction. It is not enacted law.
Iowa’s advisory board has backed seven medical cannabis recommendations, including ending patient sales tax. Legislative action would still be needed.
A proposed testing overhaul would make remediation more visible to Massachusetts cannabis shoppers. The rules still need public comment and final adoption.
The November 12 change and a limited agreement in the federal lawsuit are different developments. Here is what the state’s guidance and the filing actually say.